C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma

Autor: Rischin, D., Brungs, D., Day, F., Christie, H., Patel, V.A., Adams, G., Jackson, J.E., Schurmann, M.D.L.V., Kirtbaya, D., Shin, T.M., Hart, C.D., Stankevich, E., Li, S., Lowy, I., Han, H., Fury, M.G., Porceddu, S.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e610-e611

НАНОСТРУКТУРИРОВАННЫЕ ИЗНОСОСТОЙКИЕ ВАКУУМНО-ПЛАЗМЕННЫЕ ПОКРЫТИЯ НА ИНСТРУМЕНТЕ И ДЕТАЛЯХ МАШИН

Autor: Pobol, I., Denizhenko, A., Stankevich, E.

Publikováno v: Herald of Aeroenginebuilding; № 1 (2014): Herald of aeroenginebuilding
Вестник двигателестроения; № 1 (2014): Вестник двигателестроения
Вісник двигунобудування; № 1 (2014): Вісник двигунобудування

Structure, conmposition and physico-mechanical properties of multilayer Ti-TiCO and Ti-TiN-TiNCO-TiCO coatings was investigated depending on deposition parameters. Coatings characterized by the nanostructure with a grain size of 15´50 nm and a devel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::1624f5a572a2f34121ca017bea4846e7
http://vd.zntu.edu.ua/article/view/98305

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

97P - Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

Autor: Rischin, D., Khushalani, N.I., Schmults, C.D., Guminski, A., Chang, A.L.S., Lewis, K.D., Lim, A.M., Hernandez-Aya, L., Hughes, B.G.M., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Li, S., Chen, Z., Desai, J., Lowy, I., Fury, M.G., Migden, M.R.

Publikováno v: In Annals of Oncology December 2019 30 Supplement 11:xi35-xi36

1318P - Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)

Autor: Rischin, D. ¹, Lim, A.M. ², Schmults, C.D. ³, Khushalani, N.I. ⁴, Hughes, B.G. ⁵, Schadendorf, D. ⁶, Dunn, L.A. ⁷, Chang, A.L.S. ⁸, Hauschild, A. ⁹, Ulrich, C. ¹⁰, Eigentler, T. ¹¹, Migden, M.R. ¹², Pavlick, A.C. ¹³, Geiger, J. ¹⁴, Stankevich, E. ¹⁵, Li, S. ¹⁶, Lowy, I. ¹⁶, Fury, M.G. ¹⁶, Guminski, A. ¹⁷

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v536-v537